These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 8759032)
1. Inhibition of fibroproliferation by pentoxifylline. Activity of metabolite-1 and lack of role of adenosine receptors. Peterson TC Biochem Pharmacol; 1996 Aug; 52(4):597-602. PubMed ID: 8759032 [TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinct from an effect by cyclic AMP. Peterson TC; Slysz G; Isbrucker R Immunopharmacology; 1998 Jun; 39(3):181-91. PubMed ID: 9754904 [TBL] [Abstract][Full Text] [Related]
3. In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists. Peterson TC; Isbrucker RA; Hooper ML Immunopharmacology; 1994; 28(3):259-70. PubMed ID: 7852056 [TBL] [Abstract][Full Text] [Related]
4. Selective down-regulation of c-jun gene expression by pentoxifylline and c-jun antisense interrupts platelet-derived growth factor signaling: pentoxifylline inhibits phosphorylation of c-Jun on serine 73. Peterson TC; Peterson MR; Robertson HA; During M; Dragunow M Mol Pharmacol; 2002 Jun; 61(6):1476-88. PubMed ID: 12021409 [TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline does not act via adenosine receptors in the inhibition of the superoxide anion production of human polymorphonuclear leukocytes. Thiel M; Bardenheuer H; Pöch G; Madel C; Peter K Biochem Biophys Res Commun; 1991 Oct; 180(1):53-8. PubMed ID: 1656978 [TBL] [Abstract][Full Text] [Related]
6. Adenosine and related compounds counteract tumor necrosis factor-alpha inhibition of neutrophil migration: implication of a novel cyclic AMP-independent action on the cell surface. Sullivan GW; Linden J; Hewlett EL; Carper HT; Hylton JB; Mandell GL J Immunol; 1990 Sep; 145(5):1537-44. PubMed ID: 2166764 [TBL] [Abstract][Full Text] [Related]
7. Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells. Pinzani M; Marra F; Caligiuri A; DeFranco R; Gentilini A; Failli P; Gentilini P Br J Pharmacol; 1996 Nov; 119(6):1117-24. PubMed ID: 8937713 [TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Peterson TC Hepatology; 1993 Mar; 17(3):486-93. PubMed ID: 8095247 [TBL] [Abstract][Full Text] [Related]
9. Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: role of A2B receptors. Dubey RK; Gillespie DG; Mi Z; Jackson EK Circulation; 1997 Oct; 96(8):2656-66. PubMed ID: 9355907 [TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor and pentoxifylline modulation of collagen synthesis in myofibroblasts. Isbrucker RA; Peterson TC Toxicol Appl Pharmacol; 1998 Mar; 149(1):120-6. PubMed ID: 9512734 [TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties. Fantin M; Quintieri L; Kúsz E; Kis E; Glavinas H; Floreani M; Padrini R; Duda E; Vizler C Eur J Pharmacol; 2006 Mar; 535(1-3):301-9. PubMed ID: 16545799 [TBL] [Abstract][Full Text] [Related]
12. Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts. Strutz F; Heeg M; Kochsiek T; Siemers G; Zeisberg M; Müller GA Nephrol Dial Transplant; 2000 Oct; 15(10):1535-46. PubMed ID: 11007820 [TBL] [Abstract][Full Text] [Related]
13. ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog. Akatsuka Y; Egashira K; Katsuda Y; Narishige T; Ueno H; Shimokawa H; Takeshita A Cardiovasc Res; 1994 Jun; 28(6):906-11. PubMed ID: 7923297 [TBL] [Abstract][Full Text] [Related]
14. Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors. Sexl V; Mancusi G; Baumgartner-Parzer S; Schütz W; Freissmuth M Br J Pharmacol; 1995 Apr; 114(8):1577-86. PubMed ID: 7599925 [TBL] [Abstract][Full Text] [Related]
16. Nephroprotective mechanism(s) of pentoxifylline: reduction of erythrocyte-mediated vascular congestion and inhibition of nitric oxide release. Vadiei K; Tucker SD; Lopez-Berestein G; Wasan KM Pharmacol Toxicol; 1996 Mar; 78(3):174-80. PubMed ID: 8882351 [TBL] [Abstract][Full Text] [Related]
17. Effect of fetuin, a TGFbeta antagonist and pentoxifylline, a cytokine antagonist on hepatic stellate cell function and fibrotic parameters in fibrosis. Verma-Gandhu M; Peterson MR; Peterson TC Eur J Pharmacol; 2007 Oct; 572(2-3):220-7. PubMed ID: 17678645 [TBL] [Abstract][Full Text] [Related]